Kurowski W, Sopel R, Mincewicz G, Kozłowski M
Zakładu Alergologii PSK Nr I w Gdańsku.
Pneumonol Alergol Pol. 1997;65(11-12):783-7.
The aim of this study was to evaluate the frequency of side effects during specific immunotherapy with Catalet T and to compare the frequency of side effects between different groups of patients according to time of immunotherapy continuation (from 1 to 5 years). The study was carried on 100 patients aged from 12 to 58 years. The tolerance of Catalet was good. 83% of investigated patients finished the immunotherapy course with minimal or no side effects. The prevalence of side effects was the same independently from the time of immunotherapy.
本研究的目的是评估使用卡塔莱特T进行特异性免疫治疗期间副作用的发生频率，并根据免疫治疗持续时间（1至5年）比较不同患者组之间副作用的发生频率。该研究对100名年龄在12至58岁之间的患者进行。卡塔莱特的耐受性良好。83%的受调查患者以最小或无副作用完成了免疫治疗疗程。副作用的发生率与免疫治疗时间无关。
